Top Key Companies for Topical External Analgesic Market: Blue Emu (NFI Consumer Products), Pfizer Inc., Theraworx Relief (Avadim Technologies Inc.), Advacare Pharma, Tiger Balm (The Haw Par Corporation), Topricin (Topical Biomedics, Inc.), Reckitt Benckiser Group Plc, Boiron USA, Pure Source, Sun Pharmaceutical Industries Ltd., Glaxosmithkline Plc (GSK), Bengay (Johnson & Johnson), Salonpas (Hisamitsu Pharmaceutical Co., Inc.), Sanofi, Novartis AG, Biofreeze (The Hygenic Corporation).
Global Topical External Analgesic Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Topical External Analgesic Market Overview And Scope:
The Global Topical External Analgesic Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Topical External Analgesic utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Topical External Analgesic Market Segmentation
By Type, Topical External Analgesic market has been segmented into:
Non-opioids
Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
Methyl Salicylate
Capsaicin
Lidocaine
Other Non-opioids
By Application, Topical External Analgesic market has been segmented into:
Pharmacy & Drug Store
e-Commerce
Retail & Grocery Store
Regional Analysis of Topical External Analgesic Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Topical External Analgesic Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Topical External Analgesic market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Topical External Analgesic market.
Top Key Companies Covered in Topical External Analgesic market are:
Blue Emu (NFI Consumer Products)
Pfizer Inc.
Theraworx Relief (Avadim Technologies Inc.)
Advacare Pharma
Tiger Balm (The Haw Par Corporation)
Topricin (Topical Biomedics
Inc.)
Reckitt Benckiser Group Plc
Boiron USA
Pure Source
Sun Pharmaceutical Industries Ltd.
Glaxosmithkline Plc (GSK)
Bengay (Johnson & Johnson)
Salonpas (Hisamitsu Pharmaceutical Co.
Inc.)
Sanofi
Novartis AG
Biofreeze (The Hygenic Corporation)
Key Questions answered in the Topical External Analgesic Market Report:
1. What is the expected Topical External Analgesic Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Topical External Analgesic Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Topical External Analgesic Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Topical External Analgesic Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Topical External Analgesic companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Topical External Analgesic Markets?
7. How is the funding and investment landscape in the Topical External Analgesic Market?
8. Which are the leading consortiums and associations in the Topical External Analgesic Market, and what is their role in the market?
Research Methodology for Topical External Analgesic Market Report:
The report presents a detailed assessment of the Topical External Analgesic Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Topical External Analgesic Market by Type
5.1 Topical External Analgesic Market Overview Snapshot and Growth Engine
5.2 Topical External Analgesic Market Overview
5.3 Non-opioids
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Non-opioids: Geographic Segmentation
5.4 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Nonsteroidal Anti-Inflammatory Drug (NSAIDS): Geographic Segmentation
5.5 Methyl Salicylate
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Methyl Salicylate: Geographic Segmentation
5.6 Capsaicin
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Capsaicin: Geographic Segmentation
5.7 Lidocaine
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Lidocaine: Geographic Segmentation
5.8 Other Non-opioids
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Other Non-opioids: Geographic Segmentation
Chapter 6: Topical External Analgesic Market by Application
6.1 Topical External Analgesic Market Overview Snapshot and Growth Engine
6.2 Topical External Analgesic Market Overview
6.3 Pharmacy & Drug Store
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Pharmacy & Drug Store: Geographic Segmentation
6.4 e-Commerce
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 e-Commerce: Geographic Segmentation
6.5 Retail & Grocery Store
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Retail & Grocery Store: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Topical External Analgesic Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Topical External Analgesic Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Topical External Analgesic Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BLUE EMU (NFI CONSUMER PRODUCTS)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 PFIZER INC.
7.4 THERAWORX RELIEF (AVADIM TECHNOLOGIES INC.)
7.5 ADVACARE PHARMA
7.6 TIGER BALM (THE HAW PAR CORPORATION)
7.7 TOPRICIN (TOPICAL BIOMEDICS
7.8 INC.)
7.9 RECKITT BENCKISER GROUP PLC
7.10 BOIRON USA
7.11 PURE SOURCE
7.12 SUN PHARMACEUTICAL INDUSTRIES LTD.
7.13 GLAXOSMITHKLINE PLC (GSK)
7.14 BENGAY (JOHNSON & JOHNSON)
7.15 SALONPAS (HISAMITSU PHARMACEUTICAL CO.
7.16 INC.)
7.17 SANOFI
7.18 NOVARTIS AG
7.19 BIOFREEZE (THE HYGENIC CORPORATION)
Chapter 8: Global Topical External Analgesic Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Non-opioids
8.2.2 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
8.2.3 Methyl Salicylate
8.2.4 Capsaicin
8.2.5 Lidocaine
8.2.6 Other Non-opioids
8.3 Historic and Forecasted Market Size By Application
8.3.1 Pharmacy & Drug Store
8.3.2 e-Commerce
8.3.3 Retail & Grocery Store
Chapter 9: North America Topical External Analgesic Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Non-opioids
9.4.2 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
9.4.3 Methyl Salicylate
9.4.4 Capsaicin
9.4.5 Lidocaine
9.4.6 Other Non-opioids
9.5 Historic and Forecasted Market Size By Application
9.5.1 Pharmacy & Drug Store
9.5.2 e-Commerce
9.5.3 Retail & Grocery Store
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Topical External Analgesic Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Non-opioids
10.4.2 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
10.4.3 Methyl Salicylate
10.4.4 Capsaicin
10.4.5 Lidocaine
10.4.6 Other Non-opioids
10.5 Historic and Forecasted Market Size By Application
10.5.1 Pharmacy & Drug Store
10.5.2 e-Commerce
10.5.3 Retail & Grocery Store
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Topical External Analgesic Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Non-opioids
11.4.2 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
11.4.3 Methyl Salicylate
11.4.4 Capsaicin
11.4.5 Lidocaine
11.4.6 Other Non-opioids
11.5 Historic and Forecasted Market Size By Application
11.5.1 Pharmacy & Drug Store
11.5.2 e-Commerce
11.5.3 Retail & Grocery Store
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Topical External Analgesic Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Non-opioids
12.4.2 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
12.4.3 Methyl Salicylate
12.4.4 Capsaicin
12.4.5 Lidocaine
12.4.6 Other Non-opioids
12.5 Historic and Forecasted Market Size By Application
12.5.1 Pharmacy & Drug Store
12.5.2 e-Commerce
12.5.3 Retail & Grocery Store
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Topical External Analgesic Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Non-opioids
13.4.2 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
13.4.3 Methyl Salicylate
13.4.4 Capsaicin
13.4.5 Lidocaine
13.4.6 Other Non-opioids
13.5 Historic and Forecasted Market Size By Application
13.5.1 Pharmacy & Drug Store
13.5.2 e-Commerce
13.5.3 Retail & Grocery Store
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Topical External Analgesic Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Non-opioids
14.4.2 Nonsteroidal Anti-Inflammatory Drug (NSAIDS)
14.4.3 Methyl Salicylate
14.4.4 Capsaicin
14.4.5 Lidocaine
14.4.6 Other Non-opioids
14.5 Historic and Forecasted Market Size By Application
14.5.1 Pharmacy & Drug Store
14.5.2 e-Commerce
14.5.3 Retail & Grocery Store
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Topical External Analgesic Scope:
|
Report Data
|
Topical External Analgesic Market
|
|
Topical External Analgesic Market Size in 2025
|
USD XX million
|
|
Topical External Analgesic CAGR 2025 - 2032
|
XX%
|
|
Topical External Analgesic Base Year
|
2024
|
|
Topical External Analgesic Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Blue Emu (NFI Consumer Products), Pfizer Inc., Theraworx Relief (Avadim Technologies Inc.), Advacare Pharma, Tiger Balm (The Haw Par Corporation), Topricin (Topical Biomedics, Inc.), Reckitt Benckiser Group Plc, Boiron USA, Pure Source, Sun Pharmaceutical Industries Ltd., Glaxosmithkline Plc (GSK), Bengay (Johnson & Johnson), Salonpas (Hisamitsu Pharmaceutical Co., Inc.), Sanofi, Novartis AG, Biofreeze (The Hygenic Corporation).
|
|
Key Segments
|
By Type
Non-opioids Nonsteroidal Anti-Inflammatory Drug (NSAIDS) Methyl Salicylate Capsaicin Lidocaine Other Non-opioids
By Applications
Pharmacy & Drug Store e-Commerce Retail & Grocery Store
|